Crystal structure of destripeptide (B28-B30) insulin: implications for insulin dissociation

Citation
J. Ye et al., Crystal structure of destripeptide (B28-B30) insulin: implications for insulin dissociation, BBA-PROT ST, 1547(1), 2001, pp. 18-25
Citations number
26
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
ISSN journal
01674838 → ACNP
Volume
1547
Issue
1
Year of publication
2001
Pages
18 - 25
Database
ISI
SICI code
0167-4838(20010505)1547:1<18:CSOD(I>2.0.ZU;2-V
Abstract
Destripeptide (B28-B30) insulin (DTRI) is an insulin analogue that has much weaker association ability than native insulin but keeps most of its biolo gical activity. It can be crystallized from a solution containing zinc ions at near-neutral pH. Its crystal structure has been determined by molecular replacement and refined at 1.9 Angstrom resolution. DTRI in the crystal ex ists as a loose hexamer compared with 2Zn insulin. The hexamer only contain s one zinc ion that coordinates to the B10 His residues of three monomers. Although residues B28-B30 are located in the monomer-monomer interface with in a dimer, the removal of them can simultaneously weaken both the interact ions between monomers within the dimer and the interactions between dimers. Because the B-chain C-terminus of insulin is very flexible, we take the DT RI hexamer as a transition state in the native insulin dissociation process and suggest a possible dissociation process of the insulin hexamer based o n the DTRI structure. (C) 2001 Elsevier Science B.V. All rights reserved.